Whole-inactivated SARS-CoV-2 vaccines: from fear to hope

Authors

  • Salimi, Vahid Dept. of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  • Tahamtan, Alireza Dept. of Microbiology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
Abstract:

Undoubtedly, vaccination can be one of the promising approaches to control infectious diseases such as the COVID-19 pandemic. Inactivated viral vaccines have a history of "vaccine-induced enhanced disease", which may occur when neutralizing antibodies bind to viral antigens without blocking or clearing the infection. This can cause additional inflammation through the mechanisms described for other respiratory pathogens and lead to acute respiratory distress syndrome. Since the structure and function of SARS-CoV-2 glycoproteins are well known, vaccine manufacturers appear to be careful when inactivating the virus to completely inactivate and maintain the viral epitopes necessary for protective immune induction. It seems that caution should be taken in the usage of inactivated vaccines in children to ensure they are safe and efficacious, vaccinated children should be well monitored and any symptoms should be reported immediately.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

COVID-19: a hypothesis to prevent SARS-CoV-2 from entering respiratory cells

Coronaviruses (CoVs) are a group of viruses that induce infection in the respiratory and other systems in the human body. There are two coronaviruses that transmitted from animals to humans including severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS) (1). The novel coronavirus that appeared at first in Wuhan, China, in December 2019 was named as severe acut...

full text

SARS-CoV-2 infection: its psychiatric manifestations

Background:  The clinical presentation of SARS-CoV-2 infection was initially dominated by respiratory symptoms. However the clinical spectrum is wide and neuropsychiatric syndromes are also a source of medical concern. Our aims are to present an atypical clinical presentation of SARS-CoV-2 infection characterized by auditory hallucinations and unusual behavior and to emphasize the diversity of ...

full text

مروری به بررسی ایمونولوژیکی SARS-Cov-2

زمینه و هدف  بیماری کووید-19 یک بیماری عفونی به‌شدت مسری می‌باشد که توسط یک کروناویروس جدید ایجاد می‌شود که می‌تواند از انسان به انسان از طریق تماس نزدیک منتقل شود. هدف از مطالعه حاضر بررسی اطلاعات جدید در زمینه ایمونولوژی کووید-19 می‌باشد. مواد و روش‌ها در مطالعه مروری حاضر، از موتورهای جستجوی Google و Google Scholar و مقالات نمایه شده در پایگاه‌های علمی معتبر بین‌المللی از جمله Pub Med، MedLi...

full text

Effects of different immunization protocols and adjuvant on antibody responses to inactivated SARS-CoV vaccine.

Severe acute respiratory syndrome (SARS) is a deadly and highly infectious disease caused by SARS Coronavirus (SARS-CoV). Inactivated SARS-CoV has been explored as a vaccine against SARS-CoV; however, current knowledge of inactivated SARS-CoV vaccine is quite limited. We attempted to investigate the effects of different immunization protocols and adjuvant on the antibody responses to inactivate...

full text

SARS-CoV Sampling from 3 Portals

To the Editor: Wang et al. detected severe acute respiratory syndrome–associated coronavirus (SARSCoV) from throat wash and saliva specimens and suggested that these specimens have advantages over other specimens, including ease of procurement and safety for medical personnel (1). The virus has been detected with variable success from nasopharyngeal aspirates, nose and throat swabs, and tears (...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 24  issue 5

pages  567- 569

publication date 2022-09

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

No Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023